NEW: We've expanded Stock Detail, Screener, and Maps with new data

Stock Detail, Screener:
3, 5, 10-Year Performance
EV/EBITDA, EV/Sales
Dividend Growth (1, 3, 5 Years)
EPS & Sales Growth (3 Years)

Maps:
All from Screener plus:
ROA, ROE, ROIC
Quick & Current Ratios
LT Debt and Debt to Equity Ratios
Gross, Operating, and Net Margins

CALC

CalciMedica Inc

Jul 03 • 02:20PM ET

1.61

Dollar change +0.03
Percentage change 1.90	%

Healthcare • Biotechnology • USA • NASD

Peers: PVLA LCTX APLT COGT GALT DTIL SYBX BIVI JAGX LVTX

| Held by: VTI VXF

Scroll to Statements

Index	-	P/E	-	EPS (ttm)	-1.55	Insider Own	54.37%	Shs Outstand	13.97M	Perf Week	12.59%
Market Cap	22.49M	Forward P/E	-	EPS next Y	-1.51	Insider Trans	0.31%	Shs Float	6.37M	Perf Month	-1.23%
Enterprise Value	6.47M	PEG	-	EPS next Q	-0.35	Inst Own	22.31%	Short Float	1.73%	Perf Quarter	-12.97%
Income	-18.87M	P/S	-	EPS this Y	-26.02%	Inst Trans	105.11%	Short Ratio	4.03	Perf Half Y	-51.06%
Sales	0.00M	P/B	2.07	EPS next Y	1.63%	ROA	-71.92%	Short Interest	0.11M	Perf YTD	-54.52%
Book/sh	0.78	P/C	0.91	EPS next 5Y	-13.56%	ROE	-134.15%	52W High	5.97 -73.03%	Perf Year	-62.12%
Cash/sh	1.76	P/FCF	-	EPS past 3/5Y	62.80% 47.54%	ROIC	-96.84%	52W Low	1.42 13.38%	Perf 3Y	-85.82%
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	- -	Gross Margin	-	Volatility	11.64% 8.42%	Perf 5Y	-
Dividend TTM	-	EV/Sales	-	EPS Y/Y TTM	41.17%	Oper. Margin	-	ATR (14)	0.15	Perf 10Y	-
Dividend Ex-Date	-	Quick Ratio	5.66	Sales Y/Y TTM	-	Profit Margin	-	RSI (14)	47.03	Recom	1.00
Dividend Gr. 3/5Y	- -	Current Ratio	5.66	EPS Q/Q	-2867.44%	SMA20	-2.51%	Beta	1.20	Target Price	16.00
Payout	-	Debt/Eq	0.79	Sales Q/Q	-	SMA50	-6.62%	Rel Volume	0.79	Prev Close	1.58
Employees	14	LT Debt/Eq	0.79	Earnings	May 14 BMO	SMA200	-39.61%	Avg Volume	27.33K	Price	1.61
IPO	Sep 25, 2020	Option/Short	No / Yes	EPS/Sales Surpr.	-17.38% -	Trades		Volume	21,507	Change	1.90%

Jun-25-25 07:00AM	CalciMedica Announces Publication in the American Journal of Nephrology Discussing Design and Rationale of Phase 2 KOURAGE Trial of Auxora in AKI with Respiratory Failure (PR Newswire)
Jun-12-25 07:00AM	CalciMedica Announces Upcoming Symposium at the 43rd Vicenza Course AKI-CRRT-EBPT and Critical Care Nephrology Meeting (PR Newswire)
May-14-25 07:00AM	CalciMedica Reports First Quarter 2025 Financial Results and Provides Clinical & Corporate Updates (PR Newswire)
Apr-17-25 07:00AM	CalciMedica Announces Presentations at Upcoming Medical Meetings (PR Newswire)
Apr-02-25 12:00PM	CalciMedica Inc. (CALC) Moves to Buy: Rationale Behind the Upgrade (Zacks) -5.13%
07:00AM	Loading…
Apr-01-25 07:00AM	CalciMedica to Participate in the Jones Healthcare and Technology Innovation Conference (PR Newswire)
Mar-27-25 07:00AM	CalciMedica Reports 2024 Financial Results and Provides Clinical & Corporate Updates (PR Newswire)
Mar-05-25 07:00AM	CalciMedica Secures Credit Facility for Up to $32.5 Million (PR Newswire) -6.17%
Mar-04-25 07:00AM	CalciMedica Presents AKI Data from a Post-Hoc Analysis of the Phase 2 CARDEA trial of Auxora in Severe COVID-19 Pneumonia at the 30th International AKI & CRRT Conference (PR Newswire)
Feb-19-25 07:00AM	CalciMedica Announces Upcoming Plenary Presentation at the 30th International AKI & CRRT Conference (PR Newswire)
Feb-03-25 04:05PM	CalciMedica to Participate in the Oppenheimer 35th Annual Healthcare Life Sciences Conference (PR Newswire)
Jan-14-25 07:00AM	CalciMedica Announces Appointment of Dr. Alan Glicklich to Board of Directors (PR Newswire)
Nov-21-24 08:00AM	CalciMedica to Participate in the Piper Sandler 36th Annual Healthcare Conference (PR Newswire)
Nov-20-24 04:05PM	CalciMedica Announces Presentations at Upcoming Medical Meetings (PR Newswire)
Nov-13-24 07:00AM	CalciMedica Reports Third Quarter 2024 Financial Results and Provides Clinical & Corporate Updates (PR Newswire)
07:00AM	Loading…
Nov-07-24 07:00AM	CalciMedica Strengthens Leadership Team with Appointment of Stephen Bardin as Chief Financial Officer (PR Newswire)
Oct-30-24 10:11PM	CalciMedica Announces Pricing of Public Offering of Common Stock (PR Newswire) +22.14% -22.92%
04:50PM	CalciMedica Announces Proposed Public Offering of Common Stock (PR Newswire)
07:00AM	CalciMedica to Present Late-Breaking Positive Data, Including a Win Ratio Analysis, from Phase 2b CARPO Trial of Auxora in Acute Pancreatitis (AP) at the American College of Gastroenterology (ACG) 2024 Annual Scientific Meeting (PR Newswire)
Oct-28-24 04:05PM	CalciMedica to Host a Call to Review Full Data Set, including a Win Ratio Analysis, from Phase 2b CARPO Trial of Auxora in Acute Pancreatitis (AP) (PR Newswire)
Oct-16-24 08:00AM	CalciMedica Announces Upcoming Late-Breaker Plenary Presentation at the American College of Gastroenterology (ACG) 2024 Annual Scientific Meeting (PR Newswire)
Sep-03-24 08:00AM	CalciMedica to Present at the H.C. Wainwright 26th Annual Global Investment Conference (PR Newswire) +7.67%
Aug-12-24 04:10PM	CalciMedica Reports Second Quarter 2024 Financial Results and Provides Clinical & Corporate Updates (PR Newswire)
Jul-09-24 07:30AM	CalciMedica Announces First Patient Enrolled in Phase 2 KOURAGE Trial of Auxora in Severe Acute Kidney Injury (AKI) (PR Newswire)
Jul-08-24 08:00AM	CalciMedica Announces Presentations at Two Upcoming Healthcare Investment Conferences (PR Newswire)
Jul-01-24 08:00AM	CalciMedica Set to Join Russell Microcap Index (PR Newswire) +7.32%
Jun-27-24 08:00AM	CalciMedica Announces Positive Topline Data from Phase 2b CARPO Trial of Auxora in Acute Pancreatitis (AP) (PR Newswire) -32.40%
07:06AM	CalciMedica's calcium channel inhibitor helps subgroup of pancreatitis patients eat solids sooner (FierceBiotech.com)
Jun-26-24 04:05PM	CalciMedica to Host Conference Call to Review Topline Data from Phase 2b CARPO Trial of Auxora in Acute Pancreatitis (AP) (PR Newswire) -10.04%
May-28-24 07:53AM	CALC Stock Earnings: CalciMedica Beats EPS for Q1 2024 (InvestorPlace)
09:48AM	Loading…
May-21-24 09:48AM	3 Massively Undervalued 10-Bagger Stocks to Buy (InvestorPlace)
May-13-24 04:05PM	CalciMedica Reports First Quarter 2024 Financial Results and Provides Clinical & Corporate Updates (PR Newswire) -7.14% +6.73%
May-07-24 08:00AM	CalciMedica Announces Upcoming Presentation at Digestive Disease Week 2024 (PR Newswire)
Apr-24-24 08:00AM	CalciMedica Announces Last Patient Enrolled in Phase 2b CARPO Trial of Auxora in Acute Pancreatitis (PR Newswire) +19.61%
Apr-10-24 03:30PM	Insiders are Piling into These 10 Healthcare Stocks in 2024 (Insider Monkey)
Mar-28-24 11:53AM	CALC Stock Earnings: CalciMedica Reported Results for Q4 2023 (InvestorPlace)
07:00AM	CalciMedica Reports 2023 Financial Results and Provides Clinical & Corporate Updates (PR Newswire)
Mar-13-24 08:00AM	CalciMedica Presents Data from Preclinical Studies of Auxora in Acute Kidney Injury at the 29th International AKI & CRRT Conference (PR Newswire)
Feb-28-24 06:57PM	CalciMedica Announces Presentation of Data from a Preclinical Study of Auxora in Acute Kidney Injury at the 29th International AKI & CRRT Conference (PR Newswire)
Feb-13-24 08:00AM	CalciMedica Announces FDA Clearance of IND Application for Phase 2 Trial of Auxora for the Treatment of Severe Acute Kidney Injury (PR Newswire) -8.21%
Feb-07-24 04:05PM	CalciMedica to Present at the Oppenheimer 34th Annual Healthcare Life Sciences Conference (PR Newswire) +6.92% -9.99%
Jan-22-24 08:00AM	CalciMedica Announces Private Placement of up to Approximately $55 Million (PR Newswire) +7.09%
Dec-11-23 07:30AM	CalciMedica Collaborator St. Jude Children's Research Hospital Presents Data from Initial Cohort of CRSPA Study at 65th Annual ASH Meeting & Exposition (PR Newswire) -13.88%
Nov-09-23 07:00AM	CalciMedica Reports Third Quarter 2023 Financial Results and Provides Clinical & Corporate Updates (PR Newswire) -12.74%
Nov-02-23 09:15AM	CalciMedica Announces Presentation of Initial Data from the CRSPA Study of Auxora at the 65th Annual ASH Meeting & Exposition (PR Newswire) +10.23%
Sep-06-23 07:30AM	CalciMedica Announces Upcoming Presentations and Events in September (PR Newswire) +5.18%
Aug-31-23 07:30AM	CalciMedica to Host Acute Pancreatitis Clinical Experts Event on September 21, 2023 (PR Newswire)
Aug-11-23 07:01AM	Daily Vickers Top Insider Picks for 08/11/2023 (Argus Research)
Aug-10-23 04:05PM	CalciMedica Reports Second Quarter 2023 Financial Results and Provides Clinical & Corporate Updates (GlobeNewswire)
06:24AM	Daily Vickers Top Insider Picks for 08/10/2023 (Argus Research)
Aug-09-23 07:30AM	CalciMedica Announces First Patient Enrolled in International Expansion of CARPO Trial of Auxora in Acute Pancreatitis (AP) (GlobeNewswire) +6.06%
06:26AM	Daily Vickers Top Insider Picks for 08/09/2023 (Argus Research)
Aug-08-23 06:28AM	Daily Vickers Top Insider Picks for 08/08/2023 (Argus Research)
Aug-07-23 06:35AM	Daily Vickers Top Insider Picks for 08/07/2023 (Argus Research)
Aug-04-23 07:14AM	Daily Vickers Top Insider Picks for 08/04/2023 (Argus Research)
Aug-03-23 07:15AM	Daily Vickers Top Insider Picks for 08/03/2023 (Argus Research)
Aug-02-23 07:52AM	Daily Vickers Top Insider Picks for 08/02/2023 (Argus Research)
Aug-01-23 06:51AM	Daily Vickers Top Insider Picks for 08/01/2023 (Argus Research) -6.29%
Jul-31-23 06:44AM	Daily Vickers Top Insider Picks for 07/31/2023 (Argus Research)
Jul-28-23 07:58AM	Daily Vickers Top Insider Picks for 07/28/2023 (Argus Research)
Jul-27-23 07:10AM	Daily Vickers Top Insider Picks for 07/27/2023 (Argus Research)
Jul-26-23 01:12PM	Daily Vickers Top Insider Picks for 07/26/2023 (Argus Research)
Jul-25-23 07:16AM	Daily Vickers Top Insider Picks for 07/25/2023 (Argus Research) -6.11%
Jul-24-23 07:12AM	Daily Vickers Top Insider Picks for 07/24/2023 (Argus Research)
Jul-21-23 07:23AM	Daily Vickers Top Insider Picks for 07/21/2023 (Argus Research)
Jul-20-23 06:55AM	Daily Vickers Top Insider Picks for 07/20/2023 (Argus Research)
Jul-19-23 07:10AM	Daily Vickers Top Insider Picks for 07/19/2023 (Argus Research)
Jul-18-23 06:53AM	Daily Vickers Top Insider Picks for 07/18/2023 (Argus Research) -5.56%
Jul-17-23 07:10AM	Daily Vickers Top Insider Picks for 07/17/2023 (Argus Research) +5.16%
Jul-14-23 06:50AM	Daily Vickers Top Insider Picks for 07/14/2023 (Argus Research)
Jul-13-23 07:02AM	Daily Vickers Top Insider Picks for 07/13/2023 (Argus Research)
Jul-12-23 07:22AM	Daily Vickers Top Insider Picks for 07/12/2023 (Argus Research) +7.08%
Jul-11-23 06:08AM	Daily Vickers Top Insider Picks for 07/11/2023 (Argus Research)
Jul-10-23 06:56AM	Daily Vickers Top Insider Picks for 07/10/2023 (Argus Research)
Jul-05-23 06:46AM	Daily Vickers Top Insider Picks for 07/05/2023 (Argus Research) +13.07%
Jul-03-23 06:50AM	Daily Vickers Top Insider Picks for 07/03/2023 (Argus Research)
Jun-30-23 06:52AM	Daily Vickers Top Insider Picks for 06/30/2023 (Argus Research) -17.32%
Jun-29-23 06:49AM	Daily Vickers Top Insider Picks for 06/29/2023 (Argus Research) +11.75%
Jun-28-23 06:58AM	Daily Vickers Top Insider Picks for 06/28/2023 (Argus Research)
Jun-27-23 06:46AM	Daily Vickers Top Insider Picks for 06/27/2023 (Argus Research) +28.00%
Jun-26-23 06:41AM	Daily Vickers Top Insider Picks for 06/26/2023 (Argus Research)
Jun-23-23 09:24AM	Daily Vickers Top Insider Picks for 06/23/2023 (Argus Research) -6.76%
Jun-12-23 07:30AM	CalciMedica Announces Relisting on Nasdaq (GlobeNewswire)
Jun-06-23 07:30AM	CalciMedica Announces Publication of Preclinical Data in Journal of Clinical Investigation (JCI) Insight Supporting the Development of CRAC Channel Inhibitors for Chronic Pancreatitis (CP) (GlobeNewswire) +16.85%
May-23-23 07:30AM	CalciMedica Expands Executive Team with New Appointments (GlobeNewswire) +9.49%
May-15-23 08:55AM	CalciMedica Reports First Quarter 2023 Financial Results and Provides Clinical & Corporate Updates (GlobeNewswire)
Mar-29-23 07:53PM	Charts Point to Higher Highs, Says Oppenheimer. Heres a Stock With Over 100% Upside Potential (TipRanks) -8.76% -29.60%

CalciMedica, Inc. operates as a clinical-stage biopharmaceutical company. It focuses on developing therapies for life-threatening inflammatory diseases. The firm's product candidate, Auxora, helps in treating acute pancreatitis and asparaginase-associated pancreatitis. The company was founded by Kenneth A. Stauderman and Gonul Velicelebi in 2007 and is headquartered in La Jolla, CA.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Stauderman Kenneth A.	Chief Scientific Officer	Jul 01 '25	Buy	1.85	1,000	1,850	1,000	Jul 02 09:48 PM
Roberts Eric W	CHIEF BUSINESS OFFICER	Jun 26 '25	Buy	1.44	4,500	6,483	32,823	Jun 27 07:35 PM
Bardin Stephen	Chief Financial Officer	Jun 26 '25	Buy	1.50	2,000	3,005	3,000	Jun 26 06:30 PM
Roberts Eric W	CHIEF BUSINESS OFFICER	Jun 11 '25	Buy	1.85	5,000	9,250	28,323	Jun 13 05:05 PM
Roberts Eric W	CHIEF BUSINESS OFFICER	Jun 06 '25	Buy	1.77	5,000	8,875	23,323	Jun 09 04:08 PM
Roberts Eric W	CHIEF BUSINESS OFFICER	Jun 05 '25	Buy	1.70	5,100	8,670	18,323	Jun 09 04:08 PM
Bardin Stephen	Chief Financial Officer	May 30 '25	Buy	1.69	1,000	1,690	41,000	Jun 03 05:10 PM
MIDDLETON FRED A	Director	Dec 06 '24	Buy	2.65	4,800	12,720	36,514	Dec 06 07:12 PM
Sanderling Venture Partners VI	10% Owner	Nov 01 '24	Buy	3.75	86,867	325,751	814,300	Nov 05 03:08 PM
Sanderling Venture Partners VI	10% Owner	Nov 01 '24	Buy	3.75	877	3,289	22,479	Nov 05 03:08 PM
MIDDLETON FRED A	Director	Nov 01 '24	Buy	3.75	87,744	329,040	814,300	Nov 05 03:04 PM
MIDDLETON FRED A	Director	Nov 01 '24	Buy	3.75	20,000	75,000	31,714	Nov 05 03:04 PM
Leheny A. Rachel	CHIEF EXECUTIVE OFFICER	Nov 01 '24	Buy	3.75	20,000	75,000	130,926	Nov 01 01:25 PM
Roberts Eric W	CHIEF BUSINESS OFFICER	Nov 01 '24	Buy	3.75	53,333	199,999	164,706	Nov 01 01:24 PM
WILSON ROBERT N	Director	Nov 01 '24	Buy	3.75	53,333	199,999	417,529	Nov 01 01:22 PM
Dunn Michael J.	President and COO	Sep 09 '24	Option Exercise	1.39	11,761	16,348	11,761	Sep 11 05:00 PM
Leheny A. Rachel	CHIEF EXECUTIVE OFFICER	Aug 27 '24	Buy	4.19	1,000	4,190	110,926	Aug 27 07:44 PM
Roberts Eric W	CHIEF BUSINESS OFFICER	Aug 23 '24	Buy	3.57	5,000	17,867	46,894	Aug 26 06:00 PM
WILSON ROBERT N	Director	Aug 23 '24	Buy	3.72	54,000	200,826	364,196	Aug 26 05:57 PM
Roberts Eric W	CHIEF BUSINESS OFFICER	Aug 21 '24	Buy	4.04	5,000	20,200	44,894	Aug 22 06:02 PM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

CALC

CalciMedica Inc

Upgrade your FINVIZ experience